Heyward Donigan, Rite Aid CEO, president, and board member since
August 2019, has stepped down. The pharmacy retailer appointed a board member, Elizabeth (“Busy”) Burr, as interim CEO, effective immediately.
"Donigan's departure comes as Rite Aid has struggled to compete with pharmacy rivals CVS Health and Walgreens, both of which have made extensive inroads into the broader
field of health care," according to Chain Store Age, which also cited Rite Aid's third-quarter net loss of $67.1
billion.
Read the whole story at Chain Store Age »